 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/13/2017 |
$87.58 |
$88.84 |
$87.42 |
$88.47 |
9.17M | | 09/14/2017 |
$88.23 |
$89.32 |
$88.15 |
$89.22 |
10.27M | | 09/15/2017 |
$89.39 |
$89.69 |
$86.52 |
$87.37 |
20.44M | | 09/18/2017 |
$87.47 |
$87.81 |
$85.08 |
$85.32 |
9.66M | | 09/19/2017 |
$85.54 |
$86.66 |
$85.38 |
$86.37 |
7.56M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. |
|
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on September 13, 2017, ABBV opened at $87.58, traded as high as $88.84 and as low as $87.42, and closed at $88.47. Trading volume was a total of 9.17M shares. On September 14, 2017, ABBV opened at $88.23, traded as high as $89.32 and as low as $88.15, and closed at $89.22. Trading volume was a total of 10.27M shares. On September 15, 2017, ABBV opened at $89.39, traded as high as $89.69 and as low as $86.52, and closed at $87.37. Trading volume was a total of 20.44M shares. On September 18, 2017, ABBV opened at $87.47, traded as high as $87.81 and as low as $85.08, and closed at $85.32. Trading volume was a total of 9.66M shares. On September 19, 2017, ABBV opened at $85.54, traded as high as $86.66 and as low as $85.38, and closed at $86.37. Trading volume was a total of 7.56M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
09/19/2017 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$86.37 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
338.06 |
|
| Dividends reinvested/share: |
$9.48 |
|
| Total return: |
191.98% |
|
| Average Annual Total Return: |
25.53% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$29,196.50 |
|
| Years: |
4.71 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
09/19/2017 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$86.37 |
|
| Dividends collected/share: |
$9.48 |
|
| Total return: |
172.92% |
|
| Average Annual Total Return: |
23.75% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$27,296.28 |
|
| Years: |
4.71 |
|
|
|
| Date |
Close |
| 09/13/2017 | $88.47 | | 09/14/2017 | $89.22 | | 09/15/2017 | $87.37 | | 09/18/2017 | $85.32 | | 09/19/2017 | $86.37 |
|
|
